Biomea Fusion (NASDAQ:BMEA) shares rose after reporting positive results from its mid-stage study testing icovamenib in individuals with type 2 diabetes over a 52-week period. The stock closed up 24% ...

Type-2 diabetes is one of the most common chronic diseases in the world, characterized by high blood-sugar levels and ...

Researchers have identified several modifiable risk factors that can help prevent the potentially life-threatening condition.

Across the Arabian Peninsula, home to the Gulf Cooperation Council (GCC) states, societies have transformed within a century ...

Medical experts recognize type 5 diabetes as separate from other types, requiring specialized treatment focusing on ...

Editor's note: Part one of a five-part USA TODAY series revealing why America hasn't solved its long struggle with Type 2 diabetes. For chef Robin Ray, newly married with young stepchildren, the ...

A new GLP-1 pill from Eli Lilly has shown positive results in clinical trials. New research released Thursday morning shows a new, oral GLP-1 pill may be just as beneficial to those with Type 2 ...

Learn about type 5 diabetes, a newly recognized but long-known form linked to malnutrition, and how it differs from type 1 ...

Mounjaro shows promise for young patients with Type 2 diabetes and obesity. A recent study reveals its active ingredient, ...

Experts say the condition—formally known as latent autoimmune diabetes in adults—can result in health complications if it isn’t diagnosed and treated properly.